Enzymes in Industrial Applications: Global Markets
July 07, 2011
Wellesley, Mass. – In a recent release, ENZYMES IN INDUSTRIAL APPLICATIONS: GLOBAL MARKETS (BIO030F) from BCC Research (www.bccresearch.com), the global market value of industrial enzymes was $3.3 billion in 2010. That value is projected to be $4.4 billion in 2015, after increasing at a five-year compound annual growth rate (CAGR) of 6%.
The global market for industrial enzymes can be broken down into three segments – technical enzymes, food and beverage enzymes, and others.
The segment made up of technical enzymes was valued at nearly $1.1 billion in 2010, and in 2015 should be worth nearly $1.5 billion, yielding a CAGR of 6.6%.
The segment made up of food and beverage enzymes was valued at $975 million in 2010, and in 2015 should be worth nearly $1.3 billion, growing at a CAGR of 5.1%.
The last segment, made up of others, was worth nearly $1.3 billion in 2010 and should reach a value of nearly $1.7 billion in 2015, a CAGR of 6.2%.
Enzymes are proteins that catalyze chemical reactions. These biological catalysts lower the amount of activation energy needed and thus speed up reactions. They are used in industries such as food and beverages, in cleaning and environmental processes, and for analytical and diagnostic purposes. Some of the attractive properties enzymes offer in comparison to chemical-based reactions include higher efficiencies, increased specificity, and improved environmental compatibility.
The global market for industrial enzymes has been growing as modern industries have begun to explore the advantages of these enzymes over microorganisms used in the past. Key factors driving this market growth include new research and development spending, increasing competition, patent expiries, and new technologies. Despite the recent global economic setback, the outlook over the next five years for industrial enzymes is a positive one.
The report has a broad intended audience; more specifically, it’s of interest to chemical, biochemical, and biotechnical companies. Other industries who could find it informational include the food and beverages, animal feed, detergents, and leather industries, as well as other technical enzyme manufacturers and users.
Enzymes in Industrial Applications: Global Markets( BIO030F )
Publish Date: Jan 2011
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
Reports from Cell Biology
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum